DK0593766T3 - Pyridoncarboxylsyrederivat - Google Patents

Pyridoncarboxylsyrederivat

Info

Publication number
DK0593766T3
DK0593766T3 DK92910698T DK92910698T DK0593766T3 DK 0593766 T3 DK0593766 T3 DK 0593766T3 DK 92910698 T DK92910698 T DK 92910698T DK 92910698 T DK92910698 T DK 92910698T DK 0593766 T3 DK0593766 T3 DK 0593766T3
Authority
DK
Denmark
Prior art keywords
represent
various
derivatives
quinolone
formula
Prior art date
Application number
DK92910698T
Other languages
English (en)
Inventor
Youichi Kimura
Isao Hayakawa
Hisashi Takahashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0593766T3 publication Critical patent/DK0593766T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Stringed Musical Instruments (AREA)
  • Table Devices Or Equipment (AREA)
DK92910698T 1991-05-28 1992-05-27 Pyridoncarboxylsyrederivat DK0593766T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22542591 1991-05-28
PCT/JP1992/000687 WO1992021659A1 (fr) 1991-05-28 1992-05-27 Derive d'acide pyridonecarboxylique

Publications (1)

Publication Number Publication Date
DK0593766T3 true DK0593766T3 (da) 2000-10-09

Family

ID=16829173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92910698T DK0593766T3 (da) 1991-05-28 1992-05-27 Pyridoncarboxylsyrederivat

Country Status (16)

Country Link
US (1) US5696132A (da)
EP (1) EP0593766B1 (da)
JP (1) JP3215500B2 (da)
KR (1) KR100232937B1 (da)
AT (1) ATE196135T1 (da)
AU (1) AU661999B2 (da)
CA (1) CA2110260C (da)
DE (1) DE69231422T2 (da)
DK (1) DK0593766T3 (da)
ES (1) ES2151488T3 (da)
FI (1) FI109201B (da)
GR (1) GR3034966T3 (da)
NO (1) NO180780C (da)
RU (1) RU2100351C1 (da)
TW (1) TW212179B (da)
WO (1) WO1992021659A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3165742B2 (ja) * 1991-07-16 2001-05-14 中外製薬株式会社 キノロンカルボン酸誘導体の製造方法
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
DE4339134A1 (de) * 1993-11-16 1995-05-18 Bayer Ag 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
PT807630E (pt) * 1995-02-02 2003-08-29 Daiichi Seiyaku Co Compostos heterociclicos
WO1996024593A1 (en) * 1995-02-07 1996-08-15 Daiichi Pharmaceutical Co., Ltd. Heterocyclic spiro derivatives
JP4040091B2 (ja) * 1995-11-22 2008-01-30 第一三共株式会社 置換アミノシクロアルキルピロリジン誘導体
US6121285A (en) 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
WO1998024781A1 (en) * 1996-12-04 1998-06-11 Daiichi Pharmaceutical Co., Ltd. Substituted aminomethylpyrrolidine derivatives
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
US7977327B2 (en) 2004-05-13 2011-07-12 Daiichi Sankyo Company, Limited Substituted pyrrolidine derivative
RU2379304C2 (ru) * 2004-11-17 2010-01-20 Вакунага Фармасьютикал КО., Лтд. Новые производные пиридонкарбоновой кислоты или их соли
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
CN105330590B (zh) * 2015-10-15 2018-09-25 广州市朗启医药科技有限责任公司 西他沙星五元环侧链中间体的制备方法
CN109942488A (zh) * 2019-04-04 2019-06-28 山东省联合农药工业有限公司 一种喹啉羧酸酯类化合物及其制备方法与用途
MX2022010957A (es) 2020-03-03 2023-01-24 Twentyeight Seven Inc Compuestos que se dirigen a las proteínas de unión al arn o a las proteínas modificadoras del arn.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028978A (ja) * 1983-07-27 1985-02-14 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体
EP0191185B1 (en) * 1984-12-14 1990-03-07 Daiichi Seiyaku Co., Ltd. Quinoline-carboxylic acid derivatives
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co Pyridonecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
MY109714A (en) * 1990-10-18 1997-04-30 Daiichi Seiyaku Co Process for preparing 8-chloroquinolone derivatives
US5072001A (en) * 1990-11-30 1991-12-10 Warner-Lambert Company Certain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediates
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives

Also Published As

Publication number Publication date
DE69231422T2 (de) 2001-03-29
CA2110260C (en) 2001-12-04
AU1887292A (en) 1993-01-08
FI935243L (fi) 1994-01-11
ATE196135T1 (de) 2000-09-15
JP3215500B2 (ja) 2001-10-09
NO180780C (no) 1997-06-18
EP0593766A4 (en) 1994-12-07
GR3034966T3 (en) 2001-02-28
KR100232937B1 (ko) 1999-12-01
CA2110260A1 (en) 1992-12-10
RU2100351C1 (ru) 1997-12-27
FI109201B (fi) 2002-06-14
FI935243A0 (fi) 1993-11-25
EP0593766A1 (en) 1994-04-27
US5696132A (en) 1997-12-09
TW212179B (da) 1993-09-01
WO1992021659A1 (fr) 1992-12-10
AU661999B2 (en) 1995-08-17
NO180780B (no) 1997-03-10
EP0593766B1 (en) 2000-09-06
DE69231422D1 (de) 2000-10-12
NO934279D0 (no) 1993-11-26
ES2151488T3 (es) 2001-01-01
NO934279L (no) 1994-01-28
JPH05163244A (ja) 1993-06-29

Similar Documents

Publication Publication Date Title
FI935243A0 (fi) Pyridonkarboxylsyraderivat
ATE194835T1 (de) Pyridazinonderivat
RU93035829A (ru) Производные аминохинолона, замещенные арильной или гетероароматической группой, и анти-вич средства
FI935529A0 (fi) Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
FI922481A0 (fi) Heterocykliska derivat.
NO992230L (no) Heterocykelderivater som inhiberer faktor Xa
ES2156155T3 (es) Derivado de pirazol.
EP0767170A4 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
BG50163A3 (en) Method for preparing of acyl derivatives
TR28332A (tr) Arilasetik asit türevleri.
RU93058417A (ru) Производные пиридон-карбоновой кислоты, антимикробный агент
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
DE69128630D1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
DK0590272T3 (da) 17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disse
AU1659192A (en) Novel 2h-benzo(b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
ITMI920082A1 (it) Derivati solforati di acidi biliari
AP9400608A0 (en) "New nicotinic acid derivative".
DK0714908T3 (da) Nye 17-(3-imino-2-alkylproenyl)-5beta, 14beta-androstanderivater, der er aktive i det cardiovaskulære system, fremgansmåder
MX9803557A (es) Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producir tales compuestos.
DE69106235D1 (de) N-Oxyimidsäurederivate.